PROFUSA, INC. Effective Income Tax Rate Reconciliation Beat Percent
PROFUSA, INC. (PFSA) reported Effective Income Tax Rate Reconciliation Beat Percent of 21.00% for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-06.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationBeatPercent · last filed 2023-03-06
- PROFUSA, INC. effective income tax rate reconciliation beat percent for fiscal 2022 was 21.00%, a 0.00% change from fiscal 2021.
- PROFUSA, INC. effective income tax rate reconciliation beat percent for fiscal 2021 was 21.00%.
| Period end | Effective Income Tax Rate Reconciliation Beat Percent 12 month |
|---|---|
| 2022-12-31 | 21.00% 10-K · filed 2023-03-06 |
| 2021-12-31 | 21.00% 10-K · filed 2023-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |